<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-28T02:56:42Z</responseDate><request verb="GetRecord" identifier="oai:kostu-rdlopen.rawdatalibrary.net:kostu/10692" metadataPrefix="oai_dc">https://kostu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:kostu-rdlopen.rawdatalibrary.net:kostu/10692</identifier><datestamp>2026-10-27T23:52:38Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_kostu_10000</setSpec><setSpec>col_kostu_10001</setSpec><setSpec>com_kostu_10007</setSpec><setSpec>col_kostu_10061</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Myval Transcatheter Heart Valve: The Future of Transcatheter Valve Replacement and Significance in Current Timeline</dc:title><dc:creator>Kilic, Teoman</dc:creator><dc:creator>Coskun, Senol</dc:creator><dc:creator>Mirzamidinov, Didar</dc:creator><dc:creator>Yilmaz, Irem</dc:creator><dc:creator>Yavuz, Sadan</dc:creator><dc:creator>Sahin, Tayfun</dc:creator><dc:subject>Myval</dc:subject><dc:subject>safety</dc:subject><dc:subject>transcatheter aortic valve implantation</dc:subject><dc:subject>transcatheter heart valve</dc:subject><dc:subject>valve-in-valve implantation</dc:subject><dc:description>The Myval is a balloon-expandable transcatheter heart valve (THV) developed by Meril Life Sciences Pvt. Ltd. (Vapi, Gujarat, India) that has an innovative operator-friendly design that aids in improving deliverability and features precise deployment. Various clinical studies demonstrate its effectiveness and safety, making it a promising choice in valvular interventions. Myval has been successfully utilized as a transcatheter aortic valve implantation (TAVI) device in cases with conduction disturbances, bicuspid aortic valve anatomy, non-calcified aortic regurgitation, dysfunctional stenosed right ventricular outflow tract (RVOT) conduits, pulmonary valve replacement, mitral valve replacement, and valve-in-valve and valve-in-ring implantation procedures. Myval’s diverse sizes are also of key importance in complex cases of large annuli and complex anatomy. Further long-term studies are needed to consolidate these results. Its introduction signifies a significant advancement in cardiology, aiming to enhance patient outcomes and quality of life. In the present review, we provide an update on new-generation Myval THV series and review the available clinical data published to date with an emphasis on diverse use in specific clinical scenarios.</dc:description><dc:publisher>Multidisciplinary Digital Publishing Institute (MDPI)</dc:publisher><dc:date>2024</dc:date><dc:type>Review Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/kostu/10692</dc:identifier><dc:identifier>https://doi.org/10.3390/jcm13226857</dc:identifier><dc:identifier>2077-0383</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Clinical Medicine</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/review</dc:type><dc:identifier>https://kostu-rdlopen.rawdatalibrary.net/tr/items/kostu/10692</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>